As surgical practices continue to evolve, healthcare professionals must keep pace with new advancements and adapt their clinical approaches to meet patient needs. Across specialties, healthcare professionals are looking for practical solutions that support surgical procedures and help them manage critical challenges like bleeding control and wound management. Knowledge sharing and collaboration provide opportunities to understand these needs and exchange insights into developments across the healthcare sector.

MEDICA 2026, taking place from 16–19 November 2026 in Düsseldorf, Germany, will bring together healthcare professionals, manufacturers and industry leaders to explore new developments, exchange ideas, and build professional connections.

Looking Back at MEDICA 2025

MEDICA 2025 was a valuable opportunity for Aegis Lifesciences to connect with visitors, distributors, and industry partners from across the world. The conversations and interactions throughout the event offered opportunities to exchange perspectives, understand market needs, and strengthen professional relationships.

We sincerely thank everyone who visited our booth and took the time to engage with our team. Your interest and participation made the event a memorable experience for Aegis Lifesciences.

Here are some glimpses of our participation in MEDICA 2025.

Building on these valuable interactions, we are pleased to announce our participation in MEDICA 2026. As a global medical device manufacturer and exporter, the company offers a variety of haemostatic products designed to meet different surgical needs, with customizable options available to meet specific requirements.

What We Bring at MEDICA 2026

At MEDICA 2026, Aegis Lifesciences will present its extensive portfolio of haemostatic and wound management solutions, including absorbable gelatin haemostats, flowable haemostatic matrices, oxidized regenerated cellulose-derived products and polymeric sponges for various clinical applications.

Visitors will have the opportunity to explore the following product ranges and learn more about their intended applications.

• SURGISPON^®: It contains absorbable gelatin sponges and powders designed to support haemostasis in various surgical procedures, particularly when conventional methods, such as pressure or ligature, are ineffective or impractical. Learn more about the role of absorbable gelatin haemostats in surgical procedures.

Figure 1. SURGISPON^®: Absorbable gelatin sponge

• DENTOSPON^® : It consists of absorbable gelatin foam containing finely dispersed colloidal silver. The gelatin component supports haemostasis, while the silver ions provide antimicrobial activity against microorganisms found in the oral cavity. For more information, read about haemostatic sponges in dental and oral surgery.

Figure 2.  DENTOSPON^®: Absorbable gelatin sponge with colloidal silver

• FLOGEL^®:  An absorbable gelatin haemostatic matrix made from gelatin sponge powder (USP). It is designed to support bleeding control at tight, irregular, and difficult-to-reach surgical sites. To learn more, explore how a flowable haemostatic matrix can support bleeding control.

Figure 3.  FLOGEL^®:  Flowable gelatin haemostatic matrix

• HAEMOVET^®: It comprises absorbable gelatin-based haemostatic products intended for use in general veterinary surgical procedures. For further insights, read more about the HAEMOVET^®  in veterinary surgery.

Figure 4.  HAEMOVET^®: Absorbable haemostats for veterinary use

• Surgi-ORC^®: A natural, plant-based absorbable haemostat composed of oxidized regenerated cellulose (ORC). It is designed to help control capillary, venous, and small arteriolar bleeding during surgical procedures. For further information, explore the role of ORC in surgical bleeding control.

Figure 5.  Surgi-ORC^®: Absorbable oxidized regenerated cellulose haemostat

• SURGI-PVA™: It is polyvinyl alcohol (PVA) medical sponges designed to absorb fluid and provide local tamponade when required across nasal, ear, and ophthalmic procedures. Read more about PVA nasal packing and PVA eye spears for ophthalmic fluid control.

Figure 6.  SURGI-PVA™: Polyvinyl alcohol medical sponge dressing

Our diverse product portfolio and manufacturing capabilities enable us to address the evolving needs of healthcare providers across global markets, with a focus on consistent quality, product reliability, and regulatory compliance.

Manufacturing, Quality and Regulatory Compliance

Quality management and regulatory compliance are integral to medical device manufacturing. Our products are manufactured at a US FDA-registered facility under an ISO 13485- and MDSAP-Certified Quality Management System, supported by a DSIR-recognized R&D facility.

Our portfolio includes CDSCO-approved and CE-certified products, as well as products approved by international regulatory authorities, including Health Canada and ANVISA (Brazil). These capabilities reflect our commitment to quality, regulatory compliance, and the development of haemostatic solutions for surgical care.

Visit Aegis Lifesciences at MEDICA 2026

Aegis Lifesciences warmly welcomes healthcare professionals, distributors, and industry partners to connect, collaborate, and learn more about its product portfolio. The event details are as follows:

• Event: MEDICA 2026
• Date: 16–19 November 2026
• Venue: Hall 6, Booth B56-2
• Location: Düsseldorf, Germany

To arrange a meeting or request further information, contact marketing1@aegis-lifesciences.com.

We look forward to connecting with you at MEDICA 2026 and exchanging perspectives on the evolving needs of surgical care.